Authors:
WINSTANLEY P
KHOO S
SZWANDT S
EDWARDS G
WILKINS E
TIJA J
COKER R
MCKANE W
BEECHING N
WATKIN S
BRECKENRIDGE A
Citation: P. Winstanley et al., MARKED VARIATION IN PYRIMETHAMINE DISPOSITION IN AIDS PATIENTS TREATED FOR CEREBRAL TOXOPLASMOSIS, Journal of antimicrobial chemotherapy, 36(2), 1995, pp. 435-439
Authors:
BARRY M
HOWE JL
ORMESHER S
BACK DJ
BRECKENRIDGE AM
BERGIN C
MULCAHY F
BEECHING N
NYE F
Citation: M. Barry et al., PHARMACOKINETICS OF ZIDOVUDINE AND DIDEOXYINOSINE ALONE AND IN COMBINATION IN PATIENTS WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME, British journal of clinical pharmacology, 37(5), 1994, pp. 421-426
Authors:
BARRY M
HOWE JL
BACK DJ
SWART AM
BRECKENRIDGE AM
WELLER IVD
BEECHING N
NYE F
Citation: M. Barry et al., ZIDOVUDINE PHARMACOKINETICS IN ZIDOVUDINE-INDUCED BONE-MARROW TOXICITY, British journal of clinical pharmacology, 37(1), 1994, pp. 7-12
Authors:
BARRY M
BACK D
ORMESHER S
BEECHING N
NYE F
Citation: M. Barry et al., METABOLISM OF DIDANOSINE (DDI) BY ERYTHROCYTES - PHARMACOKINETIC IMPLICATIONS, British journal of clinical pharmacology, 36(1), 1993, pp. 87-88